(Q44253192)

1 December 2017

0 references

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression (English)

1 reference

1 December 2017

0 references

1

Stephen M Stahl

1 reference

1 December 2017

Richard Entsuah

2

1 reference

1 December 2017

Richard L Rudolph

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

1 December 2017

published in

Biological Psychiatry

1 reference

1 December 2017

volume

52

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

1166-1174

1 reference

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Evidence of the dual mechanisms of action of venlafaxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Milnacipran and selective serotonin reuptake inhibitors in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A New Depression Scale Designed to be Sensitive to Change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901425-7

10.1016/S0006-3223(02)01425-7

7 January 2021

Identifiers

DOI

1 reference

release_bg6d3vpgybf27bfpvzy2hmd6iy

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bg6d3vpgybf27bfpvzy2hmd6iy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference